Navigation Links
U.S. Patent Issued for Champions Biotechnology's Lead Oncology Drug
Date:10/13/2009

BALTIMORE, Oct. 13 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a drug development company with a preclinical platform able to predict clinical effectiveness, accelerate development and enhance the value of oncology drugs, today announced that the United States Patent and Trademark Office issued a patent on September 29, 2009 for the company's tubulin inhibitors, including its lead compound SG410. U.S. Patent No. 7,595,326 entitled "Synthesis of Novel Tubulin Polymerization Inhibitors: Benzoylphenylurea (BPU) Sulfur Analogs" protects the Company's composition of matter, pharmaceutical composition, and method of treatment for SG410. The patent is owned by Champions Biotechnology.

"This patent solidifies Champions' intellectual property position on SG410. We believe that SG410, in the new Neowater formulation we developed, has the potential to significantly impact the treatment of cancer," said Doug Burkett, Ph.D., President of Champions Biotechnology, Inc. "SG410 is Champions' first internal compound and is currently undergoing Biomerk Tumorgraft(TM) evaluation. The results of SG410 tests in our predictive platform are expected to be available soon. We are also actively evaluating high potential compounds to build our oncology drug pipeline and expect to in-license additional drugs in the near future. Studies suggest that evaluations of compounds through Biomerk Tumorgrafts will lead to more successful and efficient clinical development."

For more information regarding Champions Biotechnology's growing business and recent news, please visit www.championsbiotechnology.com.

About SG410

SG410 is an antimitotic inhibitor that was shown in Tumorgraft models to target microtubule associated protein tau (MAPT) deficient tumors with promising results as compared
'/>"/>

SOURCE Champions Biotechnology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Endologix Comments on Alleged Patent Infringement
2. GlaxoSmithKline and U.S. Patent and Trademark Office File a Motion to Dismiss Litigation Over Final Regulations
3. Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
4. Biostar Pharmaceuticals, Inc. Receives Patent for Aoxing Ganbao
5. United States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food
6. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
7. United States Patent and Trademark Office Publishes Stemedicas Patent Application for the Treatment of Diabetic Retinopathy
8. MultiCell Technologies is Granted U.S. Patent for Immortalized Human Liver Cell Lines
9. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Files Three Patent Applications
10. ALP Life Sciences, LLC Announces Nanoveson(TM) Patent Filing and Whitepaper Availability on Proposed Therapy for Non-Alcoholic Fatty Liver Disease (NAFLD) and Comorbid Diseases
11. Essentialis Meets Primary Endpoint in Phase 2b Trial of DCCR for Treatment of Hypertriglyceridemia and is Granted Extensive Patent Coverage in the US

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...20 Boston Scientific Cor...s received 510(k) clearance from the U.S. Food and... market its WallFlex® Fully Covered Esophagea...strictures (obstructions) caused by tumors in pati...cancer. ,, (Photo: http://www.newscom.com/cg...
(Date:11/20/2009)...irstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) tod...xecutive Officer, and Greg Browne, Chief Financial...ffray Health Care Conference in New York on Wednes...ence session and webcast will be audio only and no...ill host a webcast of the presentation live and by...
(Date:11/20/2009)...Newswire-FirstCall/ -- BD (Becton, Dickinson and C...ion of its acquisition of HandyLab, Inc., an Ann A...ufactures molecular diagnostic assays and automati...nnounced an exclusive agreement for BD to develop ... Jaguar(TM) platform, the first fully integrated m...
Breaking Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Miriam Hospital researcher receives more than 2412 million to study weight control 10359 1Miriam Hospital researcher receives more than 2412 million to study weight control 10359 2Miriam Hospital researcher receives more than 2412 million to study weight control 10359 3MSU becoming center of excellence for Parkinsons research 10356 1MSU becoming center of excellence for Parkinsons research 10356 2As More Cyclists Hit the Road Serious Injuries Rise 59456 1As More Cyclists Hit the Road Serious Injuries Rise 59456 2
...ival Improvement with Lower Doses of,Dexamethasone...r,Drugs in Newly Diagnosed Myeloma -, NORTH HOLLYW...ternational Myeloma Foundation (IMF) - supporting ...port for myeloma patients,families, researchers a...der lowering the dose of the steroid dexamethasone...
..., 2007 /PRNewswire/ -- Nereus,Pharmaceuticals, Inc...m marine microbial sources, and its collaborators ...s involving its cancer drug,candidates at the Amer...g in Los Angeles April 14-18. Four posters and two...and anti-tumor,activity in several tumor models fo...
Other Medicine Technology:The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients 2The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients 3Nereus Pharmaceuticals to Present Data at the American Association,for Cancer Research 2007 Annual Meeting 2Nereus Pharmaceuticals to Present Data at the American Association,for Cancer Research 2007 Annual Meeting 3Nereus Pharmaceuticals to Present Data at the American Association,for Cancer Research 2007 Annual Meeting 4Nereus Pharmaceuticals to Present Data at the American Association,for Cancer Research 2007 Annual Meeting 5
(Date:11/20/2009)..., , WASHINGTON, Nov. 20 /PRNewswire-U...olic Bishops urged the Senate to make essential ch...lace federal law on abortion funding and conscienc... care for immigrants and include strong provisions...led the Senate health care bill an "enormous disap...
(Date:11/20/2009)..., , CHICAGO, Nov. 20 /PRNewswire-USNewswir...asked the U.S. Food and Drug Administration (FDA) ...-whitening chemicals. ,, Citing concern about ...ministered without the benefit of professional con...tion said that the application of chemically based...
(Date:11/20/2009)..., , LAS VEGAS, Nov. 20 /PRNewswire-USNewswi...ry, Executive Director of the Nevada Health Care A...ion (NHCA) commends and thanks Senate Majority Lea...tion a step closer toward our goal of protecting e...sing home care, and preserving the strength and vi...
(Date:11/20/2009)..., Spot blood pressure readings in children with c...nsion even during doctor,s office visits increas...ording to research from Johns Hopkins Children,s C...ings appears online in the Journal of American Soc...od pressure measurements obtained during regular d...
(Date:11/20/2009)... Consumers save up to one-third buying 90-day supp...lthDay News) -- Buying a three-month supply of pre...ying a one-month supply, according to a new study....ns filled for 395 drugs between 2000 and 2005, and...ly instead of a one-month supply saved an average ...
Breaking Medicine News(10 mins):Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:High blood pressure easy to miss in children with kidney disease 2Health News:Three-Month Supply Lowers Drug Costs 2
... in B2B,solutions for transaction interoperability...fecs Healthcare Accelerator Suite to automate data...eal-time and batch modes,within the product and de...,challenges, state Medicaid programs are increasin...
...pt. 15 iMedica Corporation ("iMedica"),announced ...Misys,Healthcare Systems LLC ("Misys")., Under th...r the iMedica,PRM 2008 practice management (PM) an...e a license to Misys for the,new version of the iM...
...llion grant from the National Cancer Institute to ...gram that provides personally tailored education i...er of Hispanic patients who receive colorectal can... in primary care physician,s offices in New York C...
...ssor of biological sciences at Virginia Tech, has ...innate immunity network and human chronic inflamma...iabetes, and neurodegenerative diseases. The findi...rchers and physicians have long recognized that th...
...sage boards, videos and advice , , MONDAY,...lp cancer patients learn more about how they can p...unched by Northwestern University in Chicago. , "...to terms with their recent cancer diagnosis and im...
...ion (Nasdaq: OCCF ), announced that it will relea...oday, September 15, 2008. The third,quarter result...ded July,31, 2008. In conjunction with its release...rence call should call,(888) 868-9083. For interes...
Other Medicine News:Health News:Unisys Selects Edifecs Healthcare Accelerator Suite(TM) for MMIS System 2Health News:iMedica Announces Agreement with Misys 2Health News:UC Davis doctors use multimedia to increase colorectal cancer screening among Hispanics 2Health News:Key protein molecule linked to diverse human chronic inflammatory diseases 2Health News:Web Site Helps Cancer Patients With Fertility Preservation 2Health News:Optical Cable Corporation Schedules Conference Call to Discuss Third Quarter 2008 Results 2Health News:Optical Cable Corporation Schedules Conference Call to Discuss Third Quarter 2008 Results 3
...rews with NeedlePunch Needles are ideal for arthro...ment. The NeedlePunch Needles are preloaded on one...haft. As the anchor is being inserted, ensure the ...ng the handle to ensure suture slide ability for e...
FiberWire® Suture Kit
FiberSnare™
Flowstar Uroflowmeter
Medicine Products: